Improving Outcomes for Patients With High-Risk, HR-Positive/HER2-Negative Early Breast Cancer: Education and Resources for the Multidisciplinary Team

Download this resource for your patients with HR-positive/HER2-negative early breast cancer to help aid planning of their care.

Julia LaBarbera, MSN, RN, AGACNP-BC Released: November 16, 2022

Download this slideset from a live meeting series to learn about multidisciplinary approaches to managing high-risk, HR-positive/HER2-negative early breast cancer.

Erika P. Hamilton, MD
Program Director Joyce O'Shaughnessy, MD
Program Director Released: January 4, 2023

An expert discusses the impact of risk of recurrence on treatment selection for patients with early‑stage hormone receptor–positive/HER2‑negative breast cancer.

Joyce O'Shaughnessy, MD Released: November 14, 2022

Read about how managing the adverse events associated with adjuvant abemaciclib can affect patients with HR-positive/HER2 negative early breast cancer.

Julia LaBarbera, MSN, RN, AGACNP-BC Released: January 31, 2023

In this podcast episode, a patient with high-risk HR-positive/HER2-negative early breast cancer shares her personal experiences to highlight the importance of effective communication with her healthcare team.

Zoe Lanham Released: December 13, 2022

Watch this brief video in which a patient describes the importance of communication between patients and their healthcare providers.

Zoe Lanham Released: November 16, 2022